# Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study

> **NCT02848508** · PHASE2 · WITHDRAWN · sponsor: **Centre Hospitalier Universitaire, Amiens**

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02848508
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03-16
- **Primary completion:** 2017-06-07
- **Final completion:** 2017-06-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator choice
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848508, "Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02848508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*